Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saki Konomura"'
Autor:
Maya C. Poffenberger, Jennifer L. Bishop, Ryan J. Blackler, Kevin G. Haworth, Steven Booth, Shalla Hanson, Jeff R. Proctor, I-Ting Shao, Nichole K. Escalante, Dayananda Siddappa, Joel Smith, Gursev Anmole, Saki Konomura, Nicholas A. Dawson, Sifa Arrafi, Desmond Lau, Gerry Rowse, Rupert H. Davies, Thomas Spreter von Kreudenstein
Publikováno v:
Cancer Research. 83:2935-2935
IL-12 is a pleiotropic cytokine that potently stimulates anti-tumor cytotoxic T and NK cell mediated immunity. Recombinant IL-12 reduces tumor growth in multiple mouse models, but its therapeutic application has been limited by severe toxicities. Pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ce2847d4ba0b7753f41e7b03785e454
https://doi.org/10.1158/1538-7445.am2023-2935
https://doi.org/10.1158/1538-7445.am2023-2935
Autor:
Kim N. Chi, Sunil Parimi, Edmund Cp Chedgy, Saki Konomura, Joanna Vergidis, Matti Annala, Gillian Vandekerkhove, Alexander W. Wyatt, Andrea Sboner, Adam J. Donoghue, Werner J. Struss, Elie Ritch, Cameron Herberts, Antonio Hurtado-Coll, Ladan Fazli, Himisha Beltran, Janet Liew, Michael Sigouros
Publikováno v:
The Journal of Pathology. 246:244-253
Small-cell prostate carcinoma (SCPC) is an aggressive malignancy that is managed similarly to small-cell lung cancer. SCPC can evolve from prostate adenocarcinoma in response to androgen deprivation therapy, but, in rare cases, is present at initial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bcf75770eb93e940efdba960656bcff
https://doi.org/10.1002/path.5137
https://doi.org/10.1002/path.5137
Autor:
Edmund Cp, Chedgy, Gillian, Vandekerkhove, Cameron, Herberts, Matti, Annala, Adam J, Donoghue, Michael, Sigouros, Elie, Ritch, Werner, Struss, Saki, Konomura, Janet, Liew, Sunil, Parimi, Joanna, Vergidis, Antonio, Hurtado-Coll, Andrea, Sboner, Ladan, Fazli, Himisha, Beltran, Kim N, Chi, Alexander W, Wyatt
Publikováno v:
The Journal of pathology. 246(2)
Small-cell prostate carcinoma (SCPC) is an aggressive malignancy that is managed similarly to small-cell lung cancer. SCPC can evolve from prostate adenocarcinoma in response to androgen deprivation therapy, but, in rare cases, is present at initial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0d195dc8a0e96819a8f4c2eb17275c3
https://pubmed.ncbi.nlm.nih.gov/30015382
https://pubmed.ncbi.nlm.nih.gov/30015382